It Starts With
The Science

Support for Continuous Disinfection

While the healthcare industry has made significant advances to the cleaning and disinfection protocols under the training and monitoring of infection prevention teams, healthcare-associated infections still occur. Industry leaders have identified areas of concern and research calls for new, continuous or persistent disinfection technology.¹

It is important to develop either methods of continuous disinfection or a germicide with persistent antimicrobial effectiveness.¹

-William A. Rutala, PhD, MPH

Areas of Concern

50%+ of targeted touchpoints are missed, and 40% have been deemed inadequately disinfected.² Pathogens on the patient room floor have been found to spread quickly to other areas.³

Studies have clearly shown how rapidly high-touch sites are contaminated after episodic cleaning and disinfection in the Intensive Care Unit (ICU) setting.
Our current pandemic has emphasized the importance of air quality and our need to address aerosolization quickly and proactively. With proper air purification, we can reduce the spread of respiratory viruses.

Designed for Healthcare

When it comes to Healthcare-Associated Infections (HAIs,) we know there is no silver bullet. At ActivePure Medical, we believe in taking a bundled approach, which is why our engineers enhanced ActivePure Technology to specifically design a supplemental solution for the healthcare environment.

Supplemental Disinfection Technology

Continuous Disinfection

Whole-Hospital Coverage

No Labor Required

  • Supplemental Disinfection Technology
  • Continuous Disinfection
  • Whole-Hospital Coverage
  • No Labor Required

Class ll Medical Device

With the ActivePure Medical Guardian fully developed, ActivePure begin the multi-year process of Food and Drug Administration Review. Through rigorous testing, we proved to be safe for use in spaces occupied with employees and patients, cleared for no negative interaction with or from healthcare equipment, and effective against a broad spectrum of pathogens, as tested.¹

fda_800x800

Staphylococcus epidermidis (gram-positive) Bacteria

6-log Reduction After 60-Minutes

Aspergillus niger (fungal mold)

4-log Reduction After 60-Minutes

Bacillus globigii (spore-forming)

4-log Reduction After 60-Minutes

Erwinia herbicola (gram-negative) Bacteria

5-log Reduction After 60-Minutes

MS2 Bacteriophage RNA Non-Enveloped Virus

6-log Reduction After 60-Minutes

Phi-X174 Bacteriophage DNA Virus

4-log Reduction After 60-Minutes

Evidence-Based

With a team of experienced infection prevention professionals formed, the ActivePure Medical team went to work to further develop the evidence-based science behind the ActivePure Technology.¹ Our team believed the scientifically defendable evidence was required to validate our technology worked not only in laboratory settings, but also in the healthcare settings it was designed for. We believed it so much that we incorporated it into its official tagline.

Healthcare Inspired, Science Powered

Clinical Evidence

We partner with our customers to develop a robust clinical study measuring the impact of ActivePure in their facility. Below, we’ve outlined some recent studies we’ve concluded.

Medical-Surgical Intensive Care Unit
(MSICU)

A 180-Bed Suburban Medical-Surgical Intensive Care Unit (MSICU) Near New Orleans, Louisiana.

Research shows that the risk for an HAI is higher when surfaces are contaminated with 500 CFUs or greater.¹

  • 99.8% decrease in fungal CFUs on surfaces
  • 97.7% decrease in the microbial burden on floors
  • 95.9% decrease of surface microbial burden
  • 92.0% decrease in the number of surfaces that had greater than 500 CFUs

Surgical ICU (SICU) and Cardiovascular ICU (CV-ICU)

A Canadian Hospital Trialed ActivePure After Spending $30 Million in Induct HVAC UV Technology and HEPA Upgrades.

Surface Methicillin-Resistant Staphylococcus (MRSA) were Below Detection Levels (BDL) with the exception of single instance with 100% reduction.

  • 97% Reduction of Surface Staphylococcus Aureus
  • 87% Reduction of Surface Fungi
  • 83% Reduction of surface Bacteria Counts
  • 64% Reduction of Airborne Particulates

Are You Ready to Take the Next Step in
Infection Prevention?

Scroll to Top